Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities: A propensity score-matched territory-wide study

• Shuang Liu,
• Xuan Shen,
• Fen Zhang,
• Xiaoqian Shi,
• Bing Li,
• Jinfang Xu,
• Congrong Wang

Affiliations

Shuang Liu

Department of Endocrinology & Metabolism, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China

Xuan Shen

Department of Endocrinology & Metabolism, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China

Fen Zhang

Department of Pulmonary and Critical Care Medicine, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China

Xiaoqian Shi

Department of Pulmonary and Critical Care Medicine, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China

Bing Li

Department of Pulmonary and Critical Care Medicine, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China

Jinfang Xu

Corresponding author. Department of Health Statistics, Naval Medical University, Shanghai, 200433, China.; Department of Health Statistics, Naval Medical University, Shanghai, 200433, China

Congrong Wang

Corresponding author. 1279 Sanmen Road, Department of Endocrinology & Metabolism, Shanghai Fourth People's Hospital, School of Medicine. Tongji University, Shanghai 200434, China.; Department of Endocrinology & Metabolism, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China